Tenax Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-8.4M | $-8.6M | $240.8K | $59.4K |
| FY2012 | $-8.3M | $-8.3M | $17.7K | $127.5K |
| FY2013 | $-4.9M | $-4.9M | $17.2K | $185.3K |
| FY2014 | $-9.3M | $-9.3M | $9.8K | $651.5K |
| FY2015 | $-9.7M | $-9.8M | $4.2K | $117.3K |
| FY2016 | $-15.9M | $-15.9M | $2.9K | $1.1K |
| FY2017 | $-12.1M | $-12.1M | $4.5K | $79.6K |
| FY2018 | $-5.5M | $-5.5M | $7.6K | $190.1K |
| FY2019 | $-7.6M | $-7.6M | $3.6K | $0 |
| FY2020 | $-9.3M | $-9.3M | $3.5K | — |
| FY2021 | $-10.9M | $-10.9M | $5.3K | — |
| FY2022 | $-11.4M | $-11.4M | $2.3K | — |
| FY2023 | $-5.9M | $-5.9M | — | $191.0K |
| FY2024 | $-14.8M | $-14.8M | — | $1.1M |
| FY2025 | $-35.8M | $-35.8M | — | $19.2M |